Literature DB >> 16393222

Utility of color Doppler ultrasonography predicting tips dysfunction.

Juan G Abraldes1, Rosa Gilabert, Juan Turnes, Carles Nicolau, Annalisa Berzigotti, John Aponte, Concepció Bru, Jaime Bosch, Juan Carlos García-Pagán.   

Abstract

OBJECTIVES: Color Doppler ultrasonography (CDUS) has been proposed as an alternative to portal pressure gradient (PPG) measurement to detect transjugular intrahepatic portosystemic shunt (TIPS) dysfunction but with inconsistent results. This study aimed at developing and validating CDUS criteria to assess TIPS dysfunction.
METHODS: A total of 117 consecutive follow-up simultaneous CDUS and hemodynamic evaluations in 34 patients with TIPS were analyzed. TIPS dysfunction was defined as a PPG >12 mmHg. A predictive model was obtained with logistic regression and was validated in an independent, prospective sample of 119 consecutive paired CDUS/hemodynamic evaluations in 55 patients.
RESULTS: TIPS dysfunction was present in 57 of the 117 studies in the retrospective series. At multivariate analysis, mean maximum flow velocity at the portal vein (mVPmax) and direction of flow in the intrahepatic portal vein branches (FD) were the only independent predictors of TIPS dysfunction. The prediction rule for TIPS dysfunction derived from the model (mVPmax <28 cm/s when flow is hepatofugal or mVPmax <39 cm/s when flow is hepatopetal) had 90% sensitivity, 45% specificity, and negative likelihood ratio of 0.23. This prediction rule was validated both in patients with bare stents and in patients with polytetra fluoroethylene (PTFE)-covered stents, showing an overall 87% sensitivity, 57% specificity, and 0.23 negative likelihood ratio.
CONCLUSIONS: The combination of two CDUS parameters correlate with TIPS dysfunction with high sensitivity and low specificity but with a good negative likelihood ratio. TIPS catheterization can be safely avoided in half of the patients using this predictive rule.

Entities:  

Mesh:

Year:  2005        PMID: 16393222     DOI: 10.1111/j.1572-0241.2005.00290.x

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  6 in total

1.  Retrospective evaluation of early thrombosis in transjugular intrahepatic portosystemic polytetrafluoroethylene-coated shunts under 2-day postinterventional heparinization.

Authors:  Holger Goessmann; Verna Schuffenhauer; Arne Kandulski; Kilian Weigand; Ernst-Michael Jung; Wibke Uller; Gregor Scharf; Cristian Stroszczynski; Niklas Verloh
Journal:  Sci Rep       Date:  2022-06-22       Impact factor: 4.996

2.  Is color-Doppler US a reliable method in the follow-up of transjugular intrahepatic portosystemic shunt (TIPS)?

Authors:  P Ricci; V Cantisani; V Lombardi; G Alfano; U D'Ambrosio; G Menichini; E Marotta; F M Drudi
Journal:  J Ultrasound       Date:  2007-04-16

Review 3.  Diagnosis of cirrhosis and portal hypertension: imaging, non-invasive markers of fibrosis and liver biopsy.

Authors:  Bogdan Procopet; Annalisa Berzigotti
Journal:  Gastroenterol Rep (Oxf)       Date:  2017-04-17

4.  Potential Benefits of Underdilation of 8-mm Covered Stent in Transjugular Intrahepatic Portosystemic Shunt Creation.

Authors:  Jiacheng Liu; Jinqiang Ma; Chen Zhou; Chongtu Yang; Songjiang Huang; Qin Shi; Bin Xiong
Journal:  Clin Transl Gastroenterol       Date:  2021-06-18       Impact factor: 4.488

5.  Transjugular Intrahepatic Portosystemic Shunt Dysfunction: Concordance of Clinical Findings, Doppler Ultrasound Examination, and Shunt Venography.

Authors:  Joshua M Owen; Ron Charles Gaba
Journal:  J Clin Imaging Sci       Date:  2016-07-18

6.  Evaluation of Doppler-ultrasonography in the diagnosis of transjugular intrahepatic portosystemic shunt dysfunction: A prospective study.

Authors:  Charlotte Nicolas; Amélie Le Gouge; Louis d'Alteroche; Jean Ayoub; Monica Georgescu; Vincent Vidal; Denis Castaing; Jean-Pierre Cercueil; Patrick Chevallier; Jérôme Roumy; Hervé Trillaud; Louis Boyer; Vincent Le Pennec; Christophe Perret; Bruno Giraudeau; Jean-Marc Perarnau
Journal:  World J Hepatol       Date:  2017-09-28
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.